Kimberly Chong

Array ( [id] => 11568877 [patent_doc_number] => 20170107521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 15/302280 [patent_app_country] => US [patent_app_date] => 2015-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9673 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318846 [patent_doc_number] => 20150203849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'Oligonucleotide comprising an inosine for treating DMD' [patent_app_type] => utility [patent_app_number] => 14/678517 [patent_app_country] => US [patent_app_date] => 2015-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24825 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14678517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10790026 [patent_doc_number] => 20160136181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'MICRORNA DOSING REGIMENS' [patent_app_type] => utility [patent_app_number] => 14/676308 [patent_app_country] => US [patent_app_date] => 2015-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12596 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14676308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14731901 [patent_doc_number] => 10385341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Compositions for modulating SOD-1 expression [patent_app_type] => utility [patent_app_number] => 15/301004 [patent_app_country] => US [patent_app_date] => 2015-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52597 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343711 [patent_doc_number] => 09528110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP' [patent_app_type] => utility [patent_app_number] => 14/672960 [patent_app_country] => US [patent_app_date] => 2015-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25217 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10381932 [patent_doc_number] => 20150266940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'CD44 SPLICE VARIANTS IN NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/671281 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22155 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14261731 [patent_doc_number] => 10280418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => RAAV-based compositions and methods for treating amyotrophic lateral sclerosis [patent_app_type] => utility [patent_app_number] => 15/126688 [patent_app_country] => US [patent_app_date] => 2015-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 30 [patent_no_of_words] => 17052 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414693 [patent_doc_number] => 20150299703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE siRNA' [patent_app_type] => utility [patent_app_number] => 14/661810 [patent_app_country] => US [patent_app_date] => 2015-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 50744 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471568 [patent_doc_number] => 20170058352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'DIAGNOSTIC USE OF VIRUS-ENCODED MICRO RNA HSV1-MIR-H18 AND HSV2-MIR-H9-5P ON PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 15/112641 [patent_app_country] => US [patent_app_date] => 2015-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8009 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10355231 [patent_doc_number] => 20150240237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'Compositions and Methods for Inhibiting Expression of a Gene from the JC Virus' [patent_app_type] => utility [patent_app_number] => 14/645922 [patent_app_country] => US [patent_app_date] => 2015-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29654 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794373 [patent_doc_number] => 09404127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Non-liposomal systems for nucleic acid delivery' [patent_app_type] => utility [patent_app_number] => 14/642452 [patent_app_country] => US [patent_app_date] => 2015-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 71532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14642452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11715219 [patent_doc_number] => 20170183718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'METHODS AND REAGENTS FOR RIBOSWITCH ANALYSIS' [patent_app_type] => utility [patent_app_number] => 15/121815 [patent_app_country] => US [patent_app_date] => 2015-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 22719 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10282009 [patent_doc_number] => 20150167007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'TREATMENT OF SIALIDASE 4 (NEU4) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO NEU4' [patent_app_type] => utility [patent_app_number] => 14/629768 [patent_app_country] => US [patent_app_date] => 2015-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25974 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14629768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12017123 [patent_doc_number] => 09809816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG' [patent_app_type] => utility [patent_app_number] => 14/615040 [patent_app_country] => US [patent_app_date] => 2015-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26690 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14615040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374673 [patent_doc_number] => 20150259680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'NUCLEIC ACID FUNCTIONALIZED NONOPARTICLES FOR THERAPEUTIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/614111 [patent_app_country] => US [patent_app_date] => 2015-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22293 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10333556 [patent_doc_number] => 20150218561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field' [patent_app_type] => utility [patent_app_number] => 14/613181 [patent_app_country] => US [patent_app_date] => 2015-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12918 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14613181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16169721 [patent_doc_number] => 10711272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => CTLA-4 aptamer siRNA species [patent_app_type] => utility [patent_app_number] => 14/602182 [patent_app_country] => US [patent_app_date] => 2015-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 26141 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14602182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10305435 [patent_doc_number] => 20150190434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/598357 [patent_app_country] => US [patent_app_date] => 2015-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 59542 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750950 [patent_doc_number] => 20160097101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'APTAMER SPECIFIC TO COLORECTAL CANCER CELL AND APPLICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/595766 [patent_app_country] => US [patent_app_date] => 2015-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1958 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14595766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421672 [patent_doc_number] => 20170029815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'RNAi AGENTS MODIFIED AT THE 4\'-C POSITION' [patent_app_type] => utility [patent_app_number] => 15/110658 [patent_app_country] => US [patent_app_date] => 2015-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110658 [rel_patent_id] =>[rel_patent_doc_number] =>)